About the mRNA Proccess Development & CMC Summit
The 5th iteration of the mRNA Process Development & CMC Summit returns with its most senior expert-led speaker faculty to date,who will be sharing about innovative new technologies, strategies, and data tackling the bioprocessing challenges faced by the field.
Gain insight into cutting-edge strategies in circular and self-amplifying RNA, address both drug substance and drug product challenges, and delve into the shift beyond vaccines as mRNA transforms cell therapy and gene editing.
Why Attend
Amplify RNA Platforms
Understand how innovators are advancing circular and self-amplifying RNA platforms to unlock greater expression, durability, and therapeutic potential, while addressing the distinct process development and CMC challenges needed to support scalable translation.
Improve Product Purity
Explore the latest purification strategies being used to improve product purity, remove process-related impurities, and build robust downstream workflows that can support consistent, scalable mRNA manufacturing – all in our purification focus day.
RNA Analytical Tools
Gain insight into the analytical tools, characterization strategies, and control frameworks needed to better understand critical quality attributes, strengthen comparability, and support confident development across increasingly complex mRNA modalities – tailored to help guide process development experts.
Improve Delivery Performance
Learn how leaders are optimising LNP design, formulation, and manufacturability to improve delivery performance, stability, and scalability, while balancing the demands of product quality and clinical translation.
NextGen mRNA Therapies
Discover how mRNA is increasingly enabling the next generation of cell therapy and gene editing applications, and what this shift means for process development, delivery, and CMC strategy beyond vaccines.
Sequencing mRNA Quality
See how next-generation sequencing is being leveraged to deepen product understanding, strengthen quality control, and generate the data needed to support more precise and reproducible mRNA development.
Who Will You Meet?
This carefully curated audience unites senior decision-makers from vaccine and therapeutic developers with the trusted service providers delivering solutions to solve their most critical challenges.
Attending Companies Include